SIM2 has been reported to be over-expressed in prostate cancer20,21, whereas its expression is decreased in esophageal squamous cell carcinoma compared to normal tissue26, indicating SIM2 regulation is distinct by cancer types. The gene discussed is SIM2; the disease is esophageal squamous cell carcinoma.